At least 2mg of the powdered compound, or 50μL of 10mM DMSO solution.
Customized support must be requested for all anonymized compounds whose identity can not be revealed at the time of submission.
Both general-purpose and rare library screening systems are available.
Depositing compounds is less labour intensive and saves time for researchers since Hokudai-Center for drug discovery has a dedicated chemical library manager. (※2)
※1:Sometimes submitted compounds may not be registered in the chemical library.
Low purity as well as decomposition which renders the submitted chemical formula not match the mass-
spectroscopic (HRMS) data, may not be registered.
※2:Depending on the state of the sample compounds, chemical formula and chemical analysis electronic data
may be requested.
The screener offers research collaboration opportunities exclusive to confirmed biologically-active compounds.
During screening, all information regarding the compounds is anonymized. Upon confirmation of bioactivity, the screener signs a pledge prior to chemical compound information disclosure by the depositor.
※Depending on the state of the compound, some steps may be omitted.
Copyright (c) Center for Research and Education on Drug Discovery, Hokkaido University. All rights reserved.